trending Market Intelligence /marketintelligence/en/news-insights/trending/gw2afsa8f5m7ejghxqz9ew2 content esgSubNav
In This List

Scythian Biosciences appoints chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Scythian Biosciences appoints chief medical officer

Canadian pharmaceutical company Scythian Biosciences Corp. named Michael Barnes to be chief medical officer.

Barnes, a clinical neurologist, is an honorary professor of neurological rehabilitation at the University of Newcastle.